Some adolescents with T1DM also utilized mobile apps designed to provide diabetes education during the pandemic; a small randomized controlled trial found a therapeutic education and insulin dosing app to be associated with a significant decrease in adolescents’ frequency of hypoglycemia episodes and a significant increase in their treatment satisfaction [52]. The gene discussed is INS; the disease is type 1 diabetes mellitus.